Cargando…
Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma
Oral squamous cell-carcinoma (OSCC) is a common cancer which arises from the alveolar ridge, buccal mucosa, and tongue. Among OSCC, the incidence of tongue squamous cell-carcinoma (TSCC) is growing all over the world. Oral carcinogenesis has been linked to genetic mutations, chromosomal aberrations...
Autores principales: | Scuderi, Sarah Adriana, Casili, Giovanna, Filippone, Alessia, Lanza, Marika, Basilotta, Rossella, Giuffrida, Raffaella, Munaò, Stefania, Colarossi, Lorenzo, Capra, Anna Paola, Esposito, Emanuela, Paterniti, Irene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664393/ https://www.ncbi.nlm.nih.gov/pubmed/34917264 http://dx.doi.org/10.18632/oncotarget.28147 |
Ejemplares similares
-
KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation
por: Scuderi, Sarah Adriana, et al.
Publicado: (2021) -
The protective role of prolyl oligopeptidase (POP) inhibition in acute lung injury induced by intestinal ischemia-reperfusion
por: Casili, Giovanna, et al.
Publicado: (2021) -
The Protective Role of Prolyl Oligopeptidase (POP) Inhibition in Kidney Injury Induced by Renal Ischemia–Reperfusion
por: Casili, Giovanna, et al.
Publicado: (2021) -
NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression
por: Scuderi, Sarah Adriana, et al.
Publicado: (2021) -
Potential Therapeutic Effects of PPAR Ligands in Glioblastoma
por: Basilotta, Rossella, et al.
Publicado: (2022)